Skip to main content
SpringerLink
Log in

A Comparison of Step-Gradient and Sequential Density Ultracentrifugation and the Use of Lipoprotein Deficient Plasma Controls in Determining the Plasma Lipoprotein Distribution of Lipid-Associated Nystatin and Cyclosporine

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. R. A. Davis and J. E. Vance. Structure, assembly and secretion of lipoproteins. In: D. E. Vance and J. E. Vance (eds.), Biochemistry of lipids, lipoproteins and membranes. Elsevier, New York, 1996, pp. 473–493.

    Google Scholar 

  2. J. A. K. Harmony, A. L. Aleson, and B. M. McCarthy. Lipoprotein structure. In: A. M. Scanu and A. A. Spector (eds), Biochemistry and biology of plasma lipoproteins. Marcel Dekker Inc., New York, 1986, pp. 403–430.

    Google Scholar 

  3. A. Mbewu and P. N. Durrington. Lipoprotein (a): Structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85:1–14 (1990).

    Google Scholar 

  4. P. N. Durrington. Lipoprotein assembly. In: P. N. Durrington (ed.) Lipoproteins and lipids. Wright, London, 1989, pp. 255–277.

    Google Scholar 

  5. K. M. Wasan and S. M. Cassidy. Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. J. Pharm. Sci. 87:411–424 (1998).

    Google Scholar 

  6. K. M. Wasan. Modifications in plasma lipoprotein concentration and lipid composition regulate the biological activity of hydrophobic drugs. J. Pharmacol. Toxicol. Methods. 36:1–11 (1996).

    Google Scholar 

  7. M. I. Mackness and P. N. Durrington. Lipoprotein separation and analysis for clinical studies. In: C. A. Converse and E. R. Skinner (eds.). Lipoprotein Analysis: A Practical Approach, Oxford University Press, New York, 1992, pp. 11–43.

    Google Scholar 

  8. V. N. Schumaker and D. L. Puppione. Lipoprotein analysis. In: J. P. Segrest and J. J. Albers (eds.), Methods of Enzymology, Academic Press, London, 1986, 128, pp. 155–174.

    Google Scholar 

  9. K. M. Wasan, P. H. Pritchard, M. Ramaswamy, W. Wong, E. M. Donnachie, and L. J. Brunner. Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine. Pharm. Res. 14:1613–1620 (1997).

    Google Scholar 

  10. R. J. Andrade, M. I. Lucena, J. A. Gonzalez-Correa, C. Garcia-Arias, and P. Gonzalez-Santos. Short-term effect of various doses of cyclosporin A on plasma lipoproteins and its distribution in blood: an experimental study. Human Exp. Toxicol. 12:141–146 (1993).

    Google Scholar 

  11. A. M. Gardier, D. Mathe, X Guedeney, et al. Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A. Ther. Drug Monitoring 15:274–280 (1993).

    Google Scholar 

  12. S. M. Cassidy, F. W. Strobel, and K. M. Wasan. Plasma Lipoprotein Distribution of Liposomal Nystatin is influenced by protein content of high-density lipoproteins. Antimicrob. Agents Chemother. 42:1878–1888 (1998).

    Google Scholar 

  13. C. Ouyang, E. Choice, J. Holland, M. Meloche, and T. D. Madden. Liposomal cyclosporine-characterization of drug incorporation and interbilayer exchange. Transplantation 60:999–1006 (1995).

    Google Scholar 

  14. R. J. Havel, H. A. Eder, and J. H. Bragdon. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345–1353 (1955).

    Google Scholar 

  15. R. J. Cushley, W. D. Treleaven, Y. I. Parmar, R. S. Chana, and D. B. Fenske. Surface diffusion in human serum lipoproteins. Biochem. Biophys. Res. Commun. 146:1139–1145 (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada

    Kishor M. Wasan, Shawn M. Cassidy, Manisha Ramaswamy, Allison Kennedy, Frank W. Strobel & Samson P. Ng

  2. Aronex Pharmaceuticals Inc., The Woodlands, Texas, 77381

    Tak-Yee Lee

Authors
  1. Kishor M. Wasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shawn M. Cassidy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manisha Ramaswamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Allison Kennedy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frank W. Strobel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Samson P. Ng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tak-Yee Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kishor M. Wasan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wasan, K.M., Cassidy, S.M., Ramaswamy, M. et al. A Comparison of Step-Gradient and Sequential Density Ultracentrifugation and the Use of Lipoprotein Deficient Plasma Controls in Determining the Plasma Lipoprotein Distribution of Lipid-Associated Nystatin and Cyclosporine. Pharm Res 16, 165–169 (1999). https://doi.org/10.1023/A:1011951602894

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011951602894

Search

Navigation